Genor Biopharma Holdings Limited (HKG:6998)
Hong Kong
· Delayed Price · Currency is HKD 2.540
0.00 (0.00%)
Jun 6, 2025, 4:08 PM HKT
Genor Biopharma Holdings Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Net Income | -51.28 | -674.36 | -730.21 | -865.22 | -3,027 | Upgrade
|
| Depreciation & Amortization | 17.54 | 72.2 | 51.16 | 58.69 | 48.65 | Upgrade
|
| Other Amortization | 0.68 | 4.69 | 2.51 | 2.06 | 1.84 | Upgrade
|
| Loss (Gain) From Sale of Assets | 5.48 | 16.96 | 6.64 | 0.21 | 0.55 | Upgrade
|
| Asset Writedown & Restructuring Costs | 35.09 | 79.29 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 31.59 | 8.92 | - | - | - | Upgrade
|
| Stock-Based Compensation | 11.65 | 60.91 | 48.24 | 123.69 | 257.62 | Upgrade
|
| Other Operating Activities | -26.47 | 11.77 | -35.51 | 28.15 | 2,150 | Upgrade
|
| Change in Inventory | 0.7 | 7.91 | -4.71 | -22.34 | -7.66 | Upgrade
|
| Change in Accounts Payable | -58.84 | 9.5 | 2.49 | 37.93 | -11.63 | Upgrade
|
| Change in Unearned Revenue | -3.87 | 0.28 | -1.23 | -0.06 | -4.23 | Upgrade
|
| Change in Other Net Operating Assets | -84.24 | -23.18 | 83 | 13.15 | -194.72 | Upgrade
|
| Operating Cash Flow | -121.98 | -425.12 | -577.61 | -623.74 | -786.72 | Upgrade
|
| Capital Expenditures | -1.57 | -1.03 | -9.04 | -46.47 | -28.32 | Upgrade
|
| Sale of Property, Plant & Equipment | 9.58 | 7.02 | 0.02 | 0.62 | 0.05 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | -3.92 | -24.92 | -69.98 | Upgrade
|
| Investment in Securities | - | - | - | 16.51 | - | Upgrade
|
| Investing Cash Flow | 8.01 | 5.99 | -12.94 | -54.26 | -98.24 | Upgrade
|
| Short-Term Debt Issued | - | - | 69.3 | 64.2 | - | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 119.98 | Upgrade
|
| Total Debt Issued | - | - | 69.3 | 64.2 | 119.98 | Upgrade
|
| Short-Term Debt Repaid | - | - | -99 | -34.5 | - | Upgrade
|
| Long-Term Debt Repaid | -1.45 | -5.94 | -19.7 | -12.49 | -18.52 | Upgrade
|
| Total Debt Repaid | -1.45 | -5.94 | -118.7 | -46.99 | -18.52 | Upgrade
|
| Net Debt Issued (Repaid) | -1.45 | -5.94 | -49.4 | 17.21 | 101.46 | Upgrade
|
| Issuance of Common Stock | - | 0 | - | 2.72 | 2,735 | Upgrade
|
| Repurchase of Common Stock | - | - | -5.13 | - | - | Upgrade
|
| Other Financing Activities | -0.11 | -0.89 | -2.86 | -2.36 | -111.25 | Upgrade
|
| Financing Cash Flow | -1.56 | -6.82 | -57.39 | 17.57 | 3,738 | Upgrade
|
| Foreign Exchange Rate Adjustments | 8.84 | 2.73 | 36 | -68.67 | -177.2 | Upgrade
|
| Net Cash Flow | -106.69 | -423.22 | -611.94 | -729.1 | 2,676 | Upgrade
|
| Free Cash Flow | -123.55 | -426.15 | -586.65 | -670.21 | -815.03 | Upgrade
|
| Free Cash Flow Margin | -59.91% | - | -3682.19% | - | -7889.19% | Upgrade
|
| Free Cash Flow Per Share | -0.24 | -0.84 | -1.16 | -1.35 | -3.33 | Upgrade
|
| Cash Interest Paid | 0.11 | 0.89 | 2.86 | 2.36 | 2.03 | Upgrade
|
| Cash Income Tax Paid | 12.87 | - | - | - | - | Upgrade
|
| Levered Free Cash Flow | -30.34 | -220.12 | -371.35 | -402.54 | -583.59 | Upgrade
|
| Unlevered Free Cash Flow | -30.27 | -219.57 | -369.57 | -401.07 | -580.13 | Upgrade
|
| Change in Net Working Capital | 37.43 | -28.47 | -32.23 | -27.93 | 190.97 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.